Enterome secures $87M in equity, loan financing

DUBLIN – Enterome SA raised €32 million (US$38.6 million) in a series D financing round and secured access to another €40 million through a loan facility with the European Investment Bank (EIB), which gives it more than enough firepower to complete proof-of-concept trials of its lead drug candidates in Crohn's disease and in cancer.